Exogenous luteinizing hormone supplementation in controlled ovarian stimulation: why, when and to whom?-Reference-Cited by-同舟云学术

Exogenous luteinizing hormone supplementation in controlled ovarian stimulation: why, when and to whom?

Published:2018-03-05 Issue:5 Volume:34 Page:939-941
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Soave Ilaria¹,Marci Roberto²

Affiliation:

1. Department of Medical and Surgical Sciences and Translational Medicine, Sant’Andrea Hospital, Faculty of Medicine and Psychology, University of Rome “Sapienza”, Rome, Italy;

2. Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2018.1438380

Reference20 articles.

1. Recombinant luteinizing hormone priming in multiple follicular stimulation forin-vitrofertilization in downregulated patients

2. STEROIDS IN THE FOLLICULAR FLUID AND THE CORPUS LUTEUM OF THE MARE. A 'TWO-CELL TYPE' THEORY OF OVARIAN STEROID SYNTHESIS

3. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial

4. Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist Cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study

5. Compositional analyses of a human menopausal gonadotrophin preparation extracted from urine (menotropin). Identification of some of its major impurities

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of luteinizing hormone changes in GnRH antagonist protocol on the outcome of controlled ovarian hyperstimulation and embryo transfer;BMC Pregnancy and Childbirth;2023-08-23

2. The effect of luteinizing hormone changes in GnRH antagonist protocol on the outcome of controlled ovarian hyperstimulation and embryo transfer;2023-02-01

3. Novel roles of luteinizing hormone (LH) in tissue regeneration-associated functions in endometrial stem cells;Cell Death & Disease;2022-07-13